Condensed Consolidated Statements of Operations (Unaudited) - USD ($) |
3 Months Ended | 9 Months Ended | ||
|---|---|---|---|---|
Sep. 30, 2022 |
Sep. 30, 2021 |
Sep. 30, 2022 |
Sep. 30, 2021 |
|
| Revenue: | ||||
| Total revenue | $ 8,484,153 | $ 4,639,822 | $ 28,130,392 | $ 9,669,323 |
| Cost of revenue: | ||||
| Total cost of revenue | 7,888,653 | 3,239,252 | 23,876,194 | 6,196,069 |
| Gross profit | 595,500 | 1,400,570 | 4,254,198 | 3,473,254 |
| Selling, general and administrative expenses: | ||||
| Research and development expense | 616,174 | 492,221 | 1,654,395 | 1,402,185 |
| Selling, advertising and promotional expense | 1,832,916 | 1,511,682 | 7,375,364 | 2,978,620 |
| General and administrative expense | 4,713,433 | 2,995,640 | 15,256,049 | 8,174,002 |
| Total selling, general and administrative expenses | 7,162,523 | 4,999,543 | 24,285,808 | 12,554,807 |
| Operating loss | (6,567,023) | (3,598,973) | (20,031,610) | (9,081,553) |
| Other income (expense): | ||||
| Interest income | 13,333 | 90,036 | 116,928 | 222,497 |
| Interest expense | (14,255) | (5,675) | (39,766) | (8,466) |
| Other income (loss) | (1,892) | 41,167 | ||
| Gain on extinguishment of debt | 10,000 | |||
| Change in fair value of contingent consideration promissory notes | (138,877) | 347,169 | ||
| Change in fair value of short-term investments | (21,656) | (84,818) | (28,210) | |
| Change in fair value of warrant derivative liabilities | 1,164,849 | 11,585,204 | 6,726,638 | 33,274,039 |
| Gain on extinguishment of warrant derivative liabilities | 3,624,794 | 3,624,794 | ||
| Total other income | 4,647,952 | 11,647,909 | 10,732,112 | 33,469,860 |
| Income (loss) before income tax benefit | (1,919,071) | 8,048,936 | (9,299,498) | 24,388,307 |
| Income tax benefit | ||||
| Net income (loss) | (1,919,071) | 8,048,936 | (9,299,498) | 24,388,307 |
| Net loss (income) attributable to noncontrolling interests of consolidated subsidiary | 16,596 | 19,863 | (268,636) | 19,863 |
| Net income (loss) attributable to common stockholders | $ (1,902,475) | $ 8,068,799 | $ (9,568,134) | $ 24,408,170 |
| Net loss per share information: | ||||
| Basic | $ (0.04) | $ 0.16 | $ (0.19) | $ 0.49 |
| Diluted | $ (0.04) | $ 0.16 | $ (0.19) | $ 0.49 |
| Weighted average shares outstanding: | ||||
| Basic | 50,365,218 | 51,809,435 | 49,973,619 | 49,404,794 |
| Diluted | 50,365,218 | 51,809,435 | 49,973,619 | 49,404,794 |
| Product [Member] | ||||
| Revenue: | ||||
| Total revenue | $ 3,062,373 | $ 1,356,454 | $ 7,682,614 | $ 4,988,364 |
| Cost of revenue: | ||||
| Total cost of revenue | 3,262,457 | 1,197,217 | 8,154,984 | 3,776,185 |
| Service, Other [Member] | ||||
| Revenue: | ||||
| Total revenue | 5,421,780 | 3,283,368 | 20,447,778 | 4,680,959 |
| Cost of revenue: | ||||
| Total cost of revenue | $ 4,626,196 | $ 2,042,035 | $ 15,721,210 | $ 2,419,884 |
| X | ||||||||||
- Definition Change in fair value of contingent consideration promissory notes and earnout agreements. No definition available.
|
| X | ||||||||||
- Definition Change in fair value of short term investments. No definition available.
|
| X | ||||||||||
- Definition Change in fair value of warrant derivative liabilities. No definition available.
|
| X | ||||||||||
- Definition Gain on extinguishment of warrant derivative liabilities No definition available.
|
| X | ||||||||||
- Definition The aggregate cost of goods produced and sold and services rendered during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The total expense recognized in the period for promotion, public relations, and brand or product advertising. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|